Tina Smith sold Entellus Medical, Inc. (ENTL)
Tina Smith (D-MN), a U.S. Senator, has disclosed 1 trade in Entellus Medical, Inc. (ENTL) since 2018, a single sale, worth an estimated $75K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Tina Smith sold $50,001 - $100,000 of Entellus Medical, Inc. (ENTL) on January 5, 2018. Since that trade, ENTL is up +0.00% against the S&P 500 up +203.12%, an outperformance of -203.12%.
Data updated
Tina Smith's ENTL trades vs the price
ENTL is up +0.00% since Tina Smith sold on January 5, 2018, versus +203.12% for the S&P 500.
Performance since this trade
All Tina Smith ENTL trades
Tina Smith & ENTL trading FAQ
Is it legal for Tina Smith to trade Entellus Medical, Inc. (ENTL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Entellus Medical, Inc. (ENTL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Tina Smith sell ENTL?
Tina Smith disclosed a sale of $50,001 - $100,000 of Entellus Medical, Inc. (ENTL) on January 5, 2018, according to public STOCK Act filings.
How has ENTL performed since Tina Smith's trade?
Since Tina Smith sold ENTL on January 5, 2018, the stock is up +0.00%, versus +203.12% for the S&P 500 over the same period, an outperformance of -203.12%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ENTL trades?
Quantellect tracks every disclosed congressional trade in Entellus Medical, Inc. (ENTL) on the Entellus Medical, Inc. congressional trading page, which aggregates filings across all members of Congress.
Tina Smith's ENTL tradesAll congressional filings for Entellus Medical, Inc.Tina Smith's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.